Abstract:1086 Objectives: In this study, arginine-arginine-leucine (RRL) a tumor targeting peptide is designed to link the bifunctional chelator mercaptoacetyltriglycine (MAG3), aiming to explore the labeling conditions of Tc-99m and to evaluate the imaging of this probe in vivo. Methods: Tc-99m was labeled through the SnCl2 reduction method, and the main factors affecting the labeling were investigated respectively to obtain the suitable labeling conditions. The paper chromatography was used to determine the labeling rate and radiochemical purity. Cysteine replacement experiment and incubation experiment of normal saline/bovine serum albumin was utilized to evaluate the stability of Tc-99m-MAG3-RRL in vitro. HepG2 tumor-bearing models were established and after tail vein injection, gamma camera imaging and biodistribution study were respectively performed periodically. Results: The purity of MAG3-RRL was 98.94%. Under the suitable labeling conditions, the labeling rate was 93.67% ± 1.10%, and the radiochemical purity was 94.32% ± 0.19% (n=3). Tc-99m-MAG3-RRL was placed in normal saline at room temperature and 50% BSA at 37 ℃, the radiochemical purity of Tc-99m-MAG3-RRL was more than 90% (n=3) within 6 hours. The highest replacement rate of Tc-99m-MAG3-RRL was 0.57% ± 0.21% in cysteine solution, and 0.41% ± 0.04% in normal saline control (n=3, P>0.05). The distribution coefficient IgP of Tc-99m-MAG3-RRL was -0.15 ± 0.01 (n=3). Gamma camera imaging revealed substantial uptake of Tc-99m-MAG3-RRL in tumors. The specific uptake of Tc-99m-MAG3-RRL in tumor was significantly higher than that of control test after injection (P<0.05). In planar gamma imaging study, the tumors were imaged clearly at 2-4h after injection of Tc-99m-MAG3-RRL, with the highest tumor-to-muscle ratio 5.63 ± 0.40 in 30min. Biodistribution data showed that Tc-99m-MAG3-RRL was rapidly accumulated in tumor within 30min with the highest tumor-to-muscle ratio 5.50 ± 0.74. And then it was rapidly cleared from the blood and predominantly accumulated in the kidneys. Conclusions: The results show that MAG3 could successfully be connected to RRL polypeptide and further improve the labeling rate, and the preparation method of Tc-99m-MAG3-RRL is simple and fast. Tc-99m-MAG3-RRL probe has good stability in vitro. Animal study shows that Tc-99m-MAG3-RRL can be used as a potential candidate for visualization of malignant carcinomas. Keywords: Arginine-Arginine-Leucine; Tc-99m; MAG3

A Novel Tc-99m-labeled and MAG<sub>3</sub>-chelated Arginine-Arginine-Leucine containing Peptide for Tumor Imaging in Hepatoma Xenografts Model

A Novel Tc-99m-Labeled Molecular Probe For Tumor Angiogenesis Imaging In Hepatoma Xenografts Model: A Pilot Study

99Mtco(mag2-3G3-dimer): a New Integrin Αvβ3-Targeted SPECT Radiotracer with High Tumor Uptake and Favorable Pharmacokinetics

Arginine-Arginine-Leucine Peptide Targeting Heat Shock Protein 70 for Cancer Imaging

99m TcO(MAG 2 -3G 3 -dimer): a new integrin α v β 3 -targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics

A Novel 99mTc-Labeled Molecular Probe for Tumor Angiogenesis Imaging in Hepatoma Xenografts Model:A Preliminary Study

2-Mercaptoacetylglycylglycyl (MAG2) As a Bifunctional Chelator for 99Mtc-Labeling of Cyclic RGD Dimers: Effect of Technetium Chelate on Tumor Uptake and Pharmacokinetics

The preparation and biological evaluation of 99mTc-MAG3-glucose

Synthesis and Biodistribution of 99Tcm-MAG2-Ade as A Tumor Imaging Agent

[99mTc]-labeling and evaluation of a new linear peptide for imaging of glioblastoma as a αvβ3-positive tumor

Synthesis and Biodistribution of 99Mtc-Peptides Conjugated Adenine As Tumor Imaging Agents

A novel radioiodinated peptide of arginine-arginine-leucine(RRL)for biodistribution and tumor angiogenic endothelium imaging

Studies on distribution and imaging of 131I-labelled RGD peptide in mice bearing tumors

131)I Labeling and Bioactivity Evaluation of a Novel RGD Dimer Targeted to Integrin Αvβ3 Receptor

Detection of Pulmonary Metastases with the Novel Radiolabeled Molecular Probe, (99M)tc-Rrl.

Noninvasive PET Imaging of a Ga-68-Radiolabeled RRL-Derived Peptide in Hepatocarcinoma Murine Models

Evaluation of 188Re-Mag2-rgd-bombesin for Potential Prostate Cancer Therapy

Technetium-99m- Arg-Arg-Leu(g2), a Modified Peptide Probe Targeted to Neovascularization in Molecular Tumor Imaging.

Study of Novel Peptide Probe 131 I-RRL for Tumor Molecular Imaging

Imaging of 99Tcm-Cycllc RGD Tetramer in Nude Mice Bearing U87MG Human Glioma Xenografts

One-step Radiosynthesis of 18F-Alf-nota-rgd2 for Tumor Angiogenesis PET Imaging